Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 60 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 7939635

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted May 10, 2011 · Expires May 5, 2031

    granted

  2. US 7935351

    Use of CPG oligodeoxynucleotides to induce angiogenesis

    The United States of America, as represented by the Department of Health and Human Services · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  3. US 7932074

    Multivalent human-bovine rotavirus vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 26, 2011 · Expires Apr 21, 2031

    granted

  4. US 7928079

    Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  5. US 7927793

    Cell lines and host nucleic acid sequences related to infectious disease

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  6. US 7928096

    Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  7. US 7919607

    Nucleic acids encoding humanized anti-tag 72 CC49 antbodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  8. US 7919477

    Multiple CpG oligodeoxynucleotides and their use to induce an immune response

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  9. US 7919301

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  10. US 7914801

    Metabolizable oil emulsion adjuvants and vaccines for enhancing immuno-properties of antibodies and their subpopulations

    The United States of America, as represented by the Secretary of Agriculture · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  11. US 7915036

    Compositions comprising T cell receptors and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  12. US 7914788

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  13. US 7910692

    Immunogenic peptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  14. US 7910105

    Methods for treating and preventing fibrosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  15. US 7902348

    Janus family kinases and identification of immune modulators

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  16. US 7902441

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  17. US 7897575

    Treatment and prevention of vascular dementia

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  18. US 7897355

    Gene expressed in prostate cancer and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  19. US 7892738

    Pot1 alternative splicing variants

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  20. US 7892569

    Methods of altering an immune response induced by CpG oligodeoxynucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  21. US 7892786

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  22. US 7888116

    Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  23. US 7887818

    Neospora caninum vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  24. US 7887812

    Live attenuated Leishmania vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.